| Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1G93A mouse model of ALS B Kalmar, S Novoselov, A Gray, ME Cheetham, B Margulis, L Greensmith Journal of neurochemistry 107 (2), 339-350, 2008 | 227 | 2008 |
| A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis A Acevedo-Arozena, B Kalmar, S Essa, T Ricketts, P Joyce, R Kent, ... Disease models & mechanisms 4 (5), 686-700, 2011 | 136 | 2011 |
| Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy B Malik, N Nirmalananthan, AL Gray, AR La Spada, MG Hanna, ... Brain 136 (3), 926-943, 2013 | 87 | 2013 |
| Graphene active sensor arrays for long-term and wireless mapping of wide frequency band epicortical brain activity R Garcia-Cortadella, G Schwesig, C Jeschke, X Illa, AL Gray, S Savage, ... Nature communications 12 (1), 1-17, 2021 | 77 | 2021 |
| Molecular Chaperone Mediated Late-Stage Neuroprotection in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis SS Novoselov, WJ Mustill, AL Gray, JR Dick, N Kanuga, B Kalmar, ... PLoS One 8 (8), e73944, 2013 | 70 | 2013 |
| Endoplasmic reticulum stress in spinal and bulbar muscular atrophy: a potential target for therapy K Montague, B Malik, AL Gray, AR La Spada, MG Hanna, G Szabadkai, ... Brain 137 (7), 1894-1906, 2014 | 42 | 2014 |
| Role of extracellular matrix proteoglycans in immune cell recruitment AL Gray, N Pun, AJL Ridley, DP Dyer International Journal of Experimental Pathology 103 (2), 34-43, 2022 | 29 | 2022 |
| An improved adeno-associated virus vector for neurological correction of the mouse model of mucopolysaccharidosis IIIA AL Gray, C O'Leary, A Liao, L Agúndez, AS Youshani, HF Gleitz, H Parker, ... Human Gene Therapy 30 (9), 1052-1066, 2019 | 19 | 2019 |
| LRRC8A is dispensable for a variety of microglial functions and response to acute stroke JR Cook, AL Gray, E Lemarchand, I Schiessl, JP Green, MC Newland, ... Glia 70 (6), 1068-1083, 2022 | 13 | 2022 |
| FUS is not dysregulated by the spinal bulbar muscular atrophy androgen receptor polyglutamine repeat expansion P Fratta, B Malik, A Gray, AR La Spada, MG Hanna, EMC Fisher, ... Neurobiology of Aging 34 (5), 1516. e17-1516. e19, 2013 | 8 | 2013 |
| Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice AL Gray, L Annan, JRT Dick, AR La Spada, MG Hanna, L Greensmith, ... Disease models & mechanisms 13 (5), dmm042424, 2020 | 7 | 2020 |
| Chemokine CXCL4 interactions with extracellular matrix proteoglycans mediate wide-spread non-receptor mediated immune cell recruitment AL Gray, R Karlsson, ARE Roberts, AJL Ridley, N Pun, C Hughes, ... bioRxiv, 2022 | 1 | 2022 |
| The endothelial glycocalyx as a contributor to stroke pathophysiology through the activity of heparanase J Merlini, A Gray, I Schiessl, D Dyer, S Allan, C Lawrence JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 42 (1_ SUPPL), 178-178, 2022 | | 2022 |
| LRRC8A is dispensable for the microglial response to acute stroke J Cook, A Gray, E Lemanchand, I Schiessl, J Green, M Newland, D Dyer, ... JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 42 (1_ SUPPL), 264-265, 2022 | | 2022 |
| Examining the mouse cerebral endothelial glycocalyx using high resolution intravital imaging AL Gray, I Schiessl, DP Dyer International Journal of Experimental Pathology 102 (4-5), A12-A12, 2021 | | 2021 |
| First person–Anna Gray A Gray Disease Models & Mechanisms 13 (5), 2020 | | 2020 |
| Investigation of disease progression, outcome measures and therapeutic intervention in a mouse model of spinal and bulbar muscular atrophy (SBMA) AL Gray UCL (University College London), 2015 | | 2015 |
| 167 An in-vitro study of distal hereditary motor neuropathy due to homozygous HSJ1 mutations A Rossor, B Kalmar, A Gray, W Mustill, G Schiavo, ME Cheetham, ... Journal of Neurology, Neurosurgery and Psychiatry 83 (3), e1, 2012 | | 2012 |
| P20 Targeting the endogenous stress response in a mouse model of SBMA A Gray, N Nirmalananthan, B Malik, J Dick, M Hanna, L Greensmith Neuromuscular Disorders, S12, 2012 | | 2012 |
| P13 Investigating pathophysiology and therapeutic strategies in a mouse model of spinal and bulbar muscular atrophy (SBMA) A Gray, B Malik, K Montague, J Dick, MG Hanna, L Greensmith Neuromuscular Disorders, S10, 2011 | | 2011 |
